There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot because of a lack of ...

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

Pfizer’s shot fell short of its initial trial goal, but with nearly half a million Americans infected each year, the company ...

Doctors break down what you need to know about the four-dose vaccine.

If approved, the Pfizer-Valneva vaccine could become highly sought-after as Lyme disease surges in the Hudson Valley.

When Lyme disease makes the news, it's typically not for positive reasons — but Pfizer is gearing up to seek regulatory ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see ...

Lyme disease infects hundreds of thousands of people each year and now scientists may be on the verge of a breakthrough with ...

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...

An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday; ...